Hellenic Dynamics (HELD) Competitors GBX 0.95 0.00 (0.00%) As of 04/22/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock HELD vs. CEL, N4P, HLN, BXP, HIK, HCM, INDV, AMYT, APH, and AGYShould you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include Celadon Pharmaceuticals (CEL), N4 Pharma (N4P), Haleon (HLN), Beximco Pharmaceuticals (BXP), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Alliance Pharma (APH), and Allergy Therapeutics (AGY). These companies are all part of the "drug manufacturers - specialty & generic" industry. Hellenic Dynamics vs. Celadon Pharmaceuticals N4 Pharma Haleon Beximco Pharmaceuticals Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Alliance Pharma Allergy Therapeutics Hellenic Dynamics (LON:HELD) and Celadon Pharmaceuticals (LON:CEL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk, institutional ownership and community ranking. Do institutionals & insiders believe in HELD or CEL? 0.1% of Hellenic Dynamics shares are owned by institutional investors. Comparatively, 10.7% of Celadon Pharmaceuticals shares are owned by institutional investors. 72.9% of Hellenic Dynamics shares are owned by company insiders. Comparatively, 65.1% of Celadon Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is HELD or CEL more profitable? Hellenic Dynamics has a net margin of 0.00% compared to Celadon Pharmaceuticals' net margin of -4,024.62%. Celadon Pharmaceuticals' return on equity of -187.26% beat Hellenic Dynamics' return on equity.Company Net Margins Return on Equity Return on Assets Hellenic DynamicsN/A -364.21% N/A Celadon Pharmaceuticals -4,024.62%-187.26%-34.40% Does the MarketBeat Community favor HELD or CEL? Celadon Pharmaceuticals received 4 more outperform votes than Hellenic Dynamics when rated by MarketBeat users. CompanyUnderperformOutperformHellenic DynamicsN/AN/ACeladon PharmaceuticalsOutperform Votes4100.00% Underperform VotesNo Votes Which has stronger valuation & earnings, HELD or CEL? Celadon Pharmaceuticals has higher revenue and earnings than Hellenic Dynamics. Celadon Pharmaceuticals is trading at a lower price-to-earnings ratio than Hellenic Dynamics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHellenic DynamicsN/AN/A-£5.22M-£3.55-0.27Celadon Pharmaceuticals£123.38K33.70-£4.97M-£7.98-0.85 Does the media refer more to HELD or CEL? In the previous week, Hellenic Dynamics' average media sentiment score of 0.00 equaled Celadon Pharmaceuticals'average media sentiment score. Company Overall Sentiment Hellenic Dynamics Neutral Celadon Pharmaceuticals Neutral SummaryHellenic Dynamics and Celadon Pharmaceuticals tied by winning 5 of the 10 factors compared between the two stocks. Get Hellenic Dynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HELD vs. The Competition Export to ExcelMetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£1.40M£2.18B£5.35B£2.51BDividend YieldN/A2.92%5.44%4.96%P/E Ratio-0.274.3121.96131.81Price / SalesN/A467.91396.51238,154.20Price / CashN/A10.2538.2028.05Price / Book0.626.486.734.49Net Income-£5.22M£20.70B£3.21B£5.82B7 Day PerformanceN/A1.28%3.97%1.44%1 Month PerformanceN/A-3.17%-7.03%5.26%1 Year Performance-67.80%94.31%15.46%101.08% Hellenic Dynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HELDHellenic DynamicsN/AGBX 0.95flatN/AN/A£1.40MN/A-0.27N/ACELCeladon PharmaceuticalsN/AGBX 6.40-1.5%N/A-94.1%£3.93M£123,381.65-0.802,780Gap DownN4PN4 PharmaN/AGBX 0.39+2.7%N/A-52.9%£1.66M£8,841.37-1.115High Trading VolumeHLNHaleon1.2547 of 5 starsGBX 380.50-0.6%GBX 457+20.1%+14.4%£34.34B£11.07B32.0025,408News CoveragePositive NewsBXPBeximco PharmaceuticalsN/AGBX 39+2.6%N/A+6.8%£26.59B£7.08T4.185,500HIKHikma Pharmaceuticals3.4706 of 5 starsGBX 1,885-0.3%GBX 2,436.67+29.3%+4.7%£5.23B£3.74B18.509,100HCMHUTCHMEDN/AGBX 212+2.4%N/A-20.0%£2.30B£771.01M-54.111,760News CoverageGap UpINDVIndivior1.6458 of 5 starsGBX 688.50+1.0%GBX 1,650+139.7%-54.3%£1.08B£1.40B-570.871,000News CoverageGap UpAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAPHAlliance Pharma1.823 of 5 starsGBX 64.20flatGBX 6,250+9,635.2%+81.1%£347.61M£183.50M-10.3591,000AGYAllergy TherapeuticsN/AGBX 5.80+1.8%N/A+130.4%£285.07M£72.18M-5.59612News CoverageGap Up Related Companies and Tools Related Companies Celadon Pharmaceuticals Competitors N4 Pharma Competitors Haleon Competitors Beximco Pharmaceuticals Competitors Hikma Pharmaceuticals Competitors HUTCHMED Competitors Indivior Competitors Amryt Pharma Competitors Alliance Pharma Competitors Allergy Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HELD) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hellenic Dynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hellenic Dynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HELD Stock Free HELD Stock Alerts